Major pharmaceutical players Eli Lilly (NYSE:LLY), AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) reported mixed Q3 results, with each company facing distinct market forces,
Piche Resources Limited (ASX: PR2) (“Piche” or the “Company”) is pleased to announce drilling results from a further eight holes at its
Livium Ltd (ASX: LIT) (‘Livium’ or the ‘Company’) is pleased to announce that its wholly owned subsidiary Envirostream Australia Pty Ltd (‘Envirostream’)
Allup Silica Limited (ASX: APS) (“Allup” or “Company”) is pleased to announce recent exploration results from its Pink Bark Project in southern
Patronus Resources Limited (ASX: PTN; “Patronus” or “the Company”) is pleased to advise that the Northern Territory Government has approved the amended
Blackstone Minerals Limited (“Blackstone” or the “Company”) is pleased to announce that it is undertaking a partially underwritten accelerated non-renounceable pro rata
Adisyn Ltd (ASX: AI1) (“Adisyn” or the “Company”) is pleased to announce, further to its previous announcement on 23 October 2024, that
Elixir Energy Limited (“Elixir” or the “Company”) is pleased to provide an update on a new resource booking for its 100% owned
In conformity with the Disclosure Guidance and Transparency Rules (‘DTRs’) of the Financial Conduct Authority (the ‘FCA’), CleanTech Lithium, an exploration and
Astral Resources NL (ASX: AAR) (Astral or the Company) is pleased to report an updated JORC compliant (2012 Edition) Mineral Resource Estimate
